Veeva Systems Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VEEV research report →
Range $165 – $330
Price Chart
About the company
Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America.
- CEO
- Peter Gassner
- IPO
- 2013
- Employees
- 7,928
- HQ
- Pleasanton, CA, US
Get TickerSpark's AI analysis on VEEV
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $46.04B
- P/E
- 45.64
- Fwd P/E
- 30.69
- PEG
- 1.85
- P/S
- 13.31
- P/B
- 6.19
- EV/EBITDA
- 32.31
- Div Yield
- 0.00%
- Gross Margin
- 74.89%
- Op Margin
- 29.93%
- Net Margin
- 29.34%
- ROE
- 14.00%
- ROIC
- 10.38%
Latest fiscal year · YoY change
- Revenue
- $3.20B+16.3%
- Gross Profit
- $2.41B+17.9%
- Op Income
- $916.37M
- Net Income
- $908.91M+27.3%
- EPS
- $5.55+25.9%
- OCF Growth
- +29.8%
- FCF Growth
- +29.6%
- 52W High
- $310.50
- 52W Low
- $148.05
- 50D MA
- $252.68
- 200D MA
- $201.55
- Beta
- 0.97
- RSI (14)
- 62
- Avg Volume
- 1.70M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Veeva beat guidance in fiscal Q2 with $928 million of revenue and $416 million of non-GAAP operating income, while management highlighted strong CRM, commercial, and early AI momentum.· August 26, 2026
- Q2 revenue was $928 million and non-GAAP operating income was $416 million, both ahead of guidance.
- Commercial strength stood out: commercial subscriptions were up about 13% year over year, driven by broad-based gains across CRM, content, data, Crossix, and Ostro.
- Management said CRM had its best quarter ever, with over 180 customers live and one top-20 customer turning on AI in CRM for its entire field force.
- Falcon interest is high, with five early adopters and first go-lives expected this year, but Peter Gassner said Veeva is still the rate limiter because the product is early.
- R&D remains in transition from older products like eTMF and CTMS toward newer growth areas such as EDC, eCOA, RTSM, Safety, and LIMS.
Veeva reported fiscal Q2 revenue of $928 million and non-GAAP operating income of $416 million, and Peter Gassner said the quarter came in ahead of guidance. Commercial subscriptions were up about 13% year over year, including double-digit growth even excluding Crossix, with strength across CRM, content, data, Crossix, and Ostro. Management did not give full GAAP EPS in the call excerpt provided. For the rest of FY2027, Brian Van Wagener said the Falcon, Aspen, Vault agents, and AI investments are already factored into updated guidance and that there is nothing material to call out for this fiscal year.
Peter Gassner’s tone was upbeat and highly optimistic, especially on AI. He said Falcon is a new category for Veeva—‘agentic labor’—and described it as a structural advantage because it pairs with Veeva’s core applications across life sciences. He also emphasized that customers are eager to move beyond AI experimentation and that Veeva’s existing trust and relationships give it an edge in CRM win-backs, commercial growth, and new offerings like Aspen.
Brian Van Wagener focused on broad-based operating execution and the durability of the model. He called out commercial subscription growth of about 13% year over year, said the growth was broad-based across CRM, content, data, Crossix, and Ostro, and noted that Crossix still has ‘a lot of headroom for growth.’ On R&D, he said the business is transitioning from legacy products to newer ones like EDC, eCOA, RTSM, Safety, and LIMS, but that the company is confident in the long-term trajectory and has raised guidance again. He also said new-market investments, including Falcon, are being scaled with revenue and that there is nothing material to call out on spending for FY2027.
Analysts focused heavily on Falcon, Aspen, CRM win-backs, R&D mix shifts, Crossix, and capital allocation. Management said Falcon has strong interest because it offers quick cost savings, compliance, and efficiency, but the product is still early and Veeva is focused on getting the first adopters live. On CRM, Paul Shawah said Veeva has 12 of the top 20 and that the remaining two decisions should play out by year-end, while also highlighting Salesforce implementation issues and over 180 live customers at Veeva. Questions on pricing and margins drew the response that Falcon pricing will likely need to be predictable, may use enterprise-style agreements, and that gross margins should be roughly similar to software over time because more work is pushed into deterministic layers.
The bull case from this call is that Veeva is still taking share in its core businesses while building new AI and data growth vectors. Management sounded confident that Falcon, Aspen, and the broader AI platform can deepen customer relationships, shorten implementations, and expand the company’s addressable market without pressuring margins materially.
The main risks are that the newest initiatives are still early and execution-dependent, especially Falcon and Aspen. Management repeatedly said Veeva is the ‘rate limiter’ on Falcon, Aspen is not yet a revenue contributor, and the R&D growth mix is shifting away from older products toward newer ones that are still early in their adoption curves.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 91.7%
- Shares Outstanding
- 162.44M
- Float Shares
- 148.91M
of shares held by institutions
1,060 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for VEEV, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Ro KhannaHouse · CA17 | Buy | Jun 2, 26 | Filing → |
| Robert P. BresnahanHouse · PA08 | Buy | May 29, 25 | Filing → |
| Robert P. BresnahanHouse · PA08 | Sell | May 16, 25 | Filing → |
| Byron DonaldsHouse · FL19 | Sell | Mar 20, 25 | Filing → |
| Byron DonaldsHouse · FL19 | Sell | Mar 20, 25 | Filing → |
| John JamesHouse · MI10 | Buy | Nov 10, 23 | Filing → |
| John JamesHouse · MI10 | Sell | Jul 16, 24 | Filing → |
| Ro KhannaHouse · CA17 | Sell | May 23, 23 | Filing → |
| William R. KeatingHouse · MA09 | Buy | Feb 13, 23 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Jan 11, 23 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Nov 3, 22 | Filing → |
| Ro KhannaHouse · CA17 | Buy | May 23, 22 | Filing → |
| Thomas Hawley TubervilleSenate · AL | Sell | Mar 30, 22 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Feb 17, 22 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 15.37M | ▼ 60.36K |
| Blackrock, Inc. | 12.86M | ▲ 1.30M |
| Vanguard Capital Management LLC | 9.69M | ▲ 3.02M |
| Vanguard Portfolio Management LLC | 7.41M | ▲ 38.71K |
| State Street Corp | 6.71M | ▲ 3.10M |
| Principal Financial Group Inc | 4.98M | ▲ 837.66K |
| Alliancebernstein L.P. | 4.91M | ▼ 1.36M |
| Geode Capital Management, LLC | 4.51M | ▲ 1.20M |
| Linonia Partnership LP | 4.41M | ▼ 515.03K |
| Aqr Capital Management LLC | 3.50M | ▲ 901.51K |
| Price T Rowe Associates Inc | 3.16M | ▲ 1.13M |
| T. Rowe Price Investment Management, Inc. | 3.04M | ▼ 361.93K |
Held by 1,738 ETFs
Biggest fund positions in VEEV by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 1, 26 | Zuppas Eleni Nitsa | other | 2,181 |
| Oct 1, 26 | Zuppas Eleni Nitsa | other | 1,110 |
| Oct 1, 26 | Zuppas Eleni Nitsa | other | 2,181 |
| Oct 1, 26 | Van Wagener Brian | other | 1,636 |
| Oct 1, 26 | Van Wagener Brian | other | 705 |
| Oct 1, 26 | Van Wagener Brian | other | 1,636 |
| Oct 1, 26 | Schwenger Thomas D. | other | 2,907 |
| Oct 1, 26 | Schwenger Thomas D. | other | 1,272 |
| Oct 1, 26 | Schwenger Thomas D. | other | 2,907 |
| Oct 1, 26 | Rizzo Daniel J | other | 1,672 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our VEEV coverage
Recent articles, reports, and earnings notes.
No research on VEEV yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VEEV report →Veeva DQS Cleans Data for More Than 1 Million Subjects Across Over 1,000 Studies
prnewswire.com · Oct 6
Rockland Trust Co. Reduces Holdings in Veeva Systems Inc. $VEEV
defenseworld.net · Oct 5
Veeva's OpenData to Help Servier Build a Global AI Data Foundation
zacks.com · Oct 5
Veeva Systems (VEEV) Stock Sinks As Market Gains: What You Should Know
zacks.com · Oct 2
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors
zacks.com · Oct 1
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It
zacks.com · Oct 1
Servier Adopts Veeva OpenData Globally to Scale AI
prnewswire.com · Sep 30
Veeva Systems Inc. (NYSE:VEEV) Stock Now Rated “Moderate Buy” by Sell-Side Brokerages
defenseworld.net · Sep 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.